tesamorelin / ipamorelin + Blend Tesamorelin + Ipamorelin 13mg 13mg

This is a research blend of two distinct and mechanistically complementary growth hormone secretagogues, supplied together to enable dual-pathway GH axis research in a single formulation

Appropriately using of Ipamorelin is as a rule safe, but sometimes the unexpected side effects of Ipamorelin can be noted

This short-acting pulsatile effect makes it suitable for once-daily administration to support physiological GH patterns

It is FDA-approved for reducing excess visceral fat in HIV-positive patients with lipodystrophy

Results often include better sleep within weeks, followed by fat loss, muscle growth, joint support, and visible anti-aging improvements over several months

For further optimization, the central gene fragment of PapRS#0, flanked by the two Bsa I restriction sites, was subjected to error-prone PCR using the GeneMorph II random mutagenesis kit (Agilent), adjusting a mutagenesis frequency of 4 nucleotide exchanges